Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
46.50
+0.20 (0.43%)
Apr 29, 2026, 11:31 AM CST

Orient EuroPharma Company Description

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide.

Its prescription medicines include weight management, andrology, cardiovascular, respiratory, neurology, cardiovascular, metabolism, obstetrics and gynecology, antibiotic, immunology, and anti-cancer drugs.

The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids, L-arginines, agile movements, and improved sleep qualities under the Nutrifuel brand name.

In addition, the company offers dermo and cosmetic products under the Cumlaude Labs, AGLabs, Bio-Oil, and ISISPHARMAs brand names.

Further, it engages in the research and development of Multikine, an immunotherapy drug for head and neck cancer, which is in Phase III clinical study; and 2ccPA, a derivative of phospholipid to patients with symptomatic osteoarthritis of the knee, which is in Phase I clinical trial.

Orient EuroPharma Co., Ltd. was incorporated in 1982 and is based in Taipei, Taiwan.

Orient EuroPharma Co., Ltd.
Country Taiwan
Founded 1982
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 339
CEO Mon-Lin Tsai

Contact Details

Address:
No. 128, Chengde Rd.
Taipei, 112052
Taiwan
Phone 886 2 2755 4881
Website oepgroup.com

Stock Details

Ticker Symbol 4120
Exchange Taipei Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0004120001
SIC Code 2834

Key Executives

Name Position
Mon-Lin Tsai Representative Director and GM
Jack Wang Financial Officer and Accounting Officer
Liann Lai Director of Human Resources and Administrative Division
Ming-Hsia Hung Chief Audit Officer
Jack Wu Director